保健 - 第101期 - page 23
ੰ༑ᕚ
23
ɰ͊೯ତၾːА၍षٙ೯षଟձϥɳଟٜટᗫf
ˀdϞɓධ
༺ڗ
16
ϋٙӺ
೯ۍ
ତdӊ˂සᙲɝ
150–200mg
ᑔոቐٙɛ໊ʕΪːА၍ष೯षϾϥɳٙ
ɛᅰ
ۍ
݊ӊ˂ᙲɝᑔոቐ൴ཀ
300mg
ɛ໊ٙՇ
࠴
f
不同觀點的說法
༐್d
ي
ᙲɝᑔոቐٙඎԨʔഃА૰ʕᑔո
ቐٙ˥̻fˇᅰɛӊ˂ٙආʕϞ༰εٙ৷ᑔոቐd
ШՉАইʕٙᑔոቐ˥̻
ۍ
Ԩʔ
৷ܘ
fவ݊Ϊ
މ
ɛ
࿁ᑔոቐٙіϗա፲ෂਿΪձ˾ᑽഃመεΪ९ٙ
ᅂᚤdʔঐ˸ɓ฿ΌfЇ৷ᑔոቐභঐˀ㉿ή
ҵՓӿᛔІԒΥϓᑔոቐdʔΝᝈᓃٙਖ਼Ӻᗇ
ྼjᎇഹᑔոቐᙲɝඎٙɽඎᄣ̋dவ၇
ࠋ
ˀ㉿ٙ
ዚՓ
ܘ
Ҟ͂ॎəfεਗ
ي
ྼ᜕ձ
ݴ
Бषኪሜ
ݟ
ٙഐ
؈
ѩՑΙᗇfԷνՊٙਗ
ي
ྼ᜕ఱ݊˸৷
ᑔոቐཱࣘᒸቮՄɿd
ܘ
ҞՄɿఱ೯͛əਗএഎᅵ
ʷdШί৾˟ᒸቮ৷ᑔոቐ
ܝي
dՄɿٙਗএ
എᅵʷɦ̙Ӊᔷf
ਗ
ي
ྼ᜕
א
ʔঐ˾
ڌ
ɛdԟჿ໊ٙ
ݴ
Бषኪ
ሜ
ݟ
ʕʱؓҢ
ࡁ
ঐՑʡჿճkҢίҷࠧක׳
ۃ
d
ᄿɽ֢͏ጯʕཱིձই
ٴ
࿁༰ˇ༆׳
ۃ
һ
ޟ
d
ːА၍षٙ೯षଟձϥɳଟ༰Эfҷࠧක׳
ܝ
ᎇഹ
ɛ
ࡁ
͛
ݺ
˥̻ٙʔᓙ৷d৷ᑔոቐභ൳Ը൳ᔮ
బdഐ
؈
Аইମ੬ٙɛᅰᜑᄣ̋f
2007~2008
ϋd
Ң
20
๋˸ɪɛ໊ᑔոቐ˥̻ၾ
2002
ϋˢᄣ̋ə
23.9
%
fኽᛆ
۾
ਖ਼ʱؓપdҢАইମ੬ٙɛᅰ
ʊ൴ཀ
2
ᄂ
2002
ϋ¨ʕੰɽ༟ࣘ©ʮбٙАইମ
੬ɛᅰ
މ
1.6
ᄂdːА၍षٙ
ܢ
ːЄϥձ໘ϥ
೯षଟձϥɳଟɰᜑᄣ৷dϾ˲˚ᒈϋჀʷf
ν
؈
Ⴍd৷ᑔոቐභʔ˾
ڌ
А૰ʕᑔոቐ˥̻d
Ͼ˲৷ᑔոቐභঐˀ㉿ήҵՓӿᛔІԒᑔոቐ
Υϓٙଣሞ݊ҁΌ͍ᆽٙdԟჿd
ڐ
ϋԸːА၍ष
ձ৷Аইसٙઃ٫ʔึԟჿεf್d
ܢ
ːЄ
ϥٙ೯षΪ९
ܘ
εdመν৷АᏀe٭
ߛ
eˇਗeі
ഃfШ݊dϞɓ΅
ݴ
Бषኪሜ
ܘݟ
ঐႭਪᕚf
̏ԯ̹
1984–1999
ϋdϓɛАᑔոቐ˥̻ᄣ̋
24
%
40mg
%
dːЄϥٙϥɳଟӲ
35–44
๋ᄣ̋
154
%
f˺ʱؓdરৰəመν৷АᏀeіe٭
ߛ
eˇਗഃΚᎈΪ९̮d
77
%
ٙઃ٫೯षᓥΪᑔո
ቐᄣ৷f
2014
ϋίАইჯਹٙӺආ࢝ʕϞɓධ
މ
ಂ
7
ϋٙ
IMPROVE-IT
Ӻɤʱ˿ɛቤᜓfӺ٫˸˼͓ᗳᖹ
ي
ʕԔͽ˼͓ԣ
ط
ਗএഎᅵʷːА၍षdա༊
٫
18144
ԷdԔͽ˼͓ʍཫ
ܝ
dա༊٫ٙЭ
ܓ
ইஐ
ͣᑔոቐ
LDL-C
ࠥЇ
69.5mg
%
dഐ
؈
ᐼːА၍ԫ
ࠬᎈࠥЭ
34.7
%
fίϤਿᓾɪd̋͜ə໑༸ᑔոቐі
ϗҵՓኒԱұ̺
Ezetimibe
dഐ
؈
LDL-C
͟
69.5
%
ආɓӉࠥЇ
53.7
%
fၾఊॱᏐ͜Ԕͽ˼͓ˢdᑌ͜
ଡ଼ٙᐼːА၍ԫ࿁ࠬᎈආɓӉɨࠥ
6.4
%
dഒ࿁
ࠬᎈආɓӉɨࠥ
2
%
dॹАʕࠬᎈࠥЭ
21
%
f
வɓӺϓ
؈
ԴҢ
ࡁ
ႩᗆՑԣ
ط
ਗএഎᅵʷ
ːА၍षd˼͓ᗳᖹ
ي
Ԩ
ڢ
ɓ،ዹӸfՉϣd࿁
ڗ
ಂ˸Ը˰
ޢ
Փ֛ٙːА၍ष৷Κઃ٫ٙ
LDL-C
ͦᅺ
࠽
<70
mg%
ٙɨࠢ݊εˇkʔ༉f݊щࠥ
ΎЭɓԬึһλkɰ݊
ࡈ
͊ٝᅰfவ
ࡈ
Ӻѓൡ
Ң
ࡁ
LDL-C 53.7
mg%
༰
69.5
mg%
ঐආɓӉᐏूdɰ
ఱ݊εਖ਼
੬ࡁ
Ⴍٙ¨ЭɓԬһλ©
Even Lower is
Even Better
fһ
࠽
ء
จٙ݊d༈Ӻ
ה
ٙ͜ᖹ
ي
ৰ੬ٙ˼͓ᗳᖹ
ي
̮d̋͜ə໑༸ᑔոቐіϗҵ
Փኒf
٫ۃ
݊ӿᛔΥϓᑔոቐٙҵՓኒd
ۆ٫ܝ
݊
ڜ
ᓙᑔոቐ໑༸іϗfኽϤdҢ
ࡁ
̙˸Ъνɨٙ
પᓙdίԣ
ط
ਗএഎᅵʷːА၍ٙԣ
ط
ʕᏐ͜
˼͓ᗳ
א
Չ˼ࠥЭ
LDL-C
ᖹ
ي
ٙΝࣛdಯˇᙲɝ৷ᑔ
ոቐභdԱұ̺ٙЪ͜d
ڢ
݊һλٙ
ʍཫણ݄k
ᛡϤdง˸
ߕމ
ਗ਼
ࡌ
ҷ
2015
ϋ֢͏ጯܸ
ی
d
՟ऊᑔոቐӊ˂ᙲɝ֛ٙඎdԨ
ڢ
̙՟ʘᑘfҢ
ࡁ
ʔᏐ¨ᩒ⪅ኪӉd؇݄ࣖ᜶©dһʔᏐ༈ೌ
ה
ᚥҚ
කԂɿɽҞϢdٝ¨ཀʔʿ©ٙ༸ଣfҢ
ࡁ
ʥ
್Ꮠ༈ܵ¨၍Иᄘdᒕකၺ©dѩፅጯٙੰ͛
ݺ
˙όf
1...,13,14,15,16,17,18,19,20,21,22
24,25,26,27,28,29,30,31,32,33,...84